Diffusion Pharmaceuticals Inc. | Separation Agreements | Business Contracts

Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Christopher D. Galloway, M.D (Filed With SEC on March 24, 2023)

Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Raven Jaeger (Filed With SEC on March 24, 2023)

Form of Separation Agreement and General Release by and between Diffusion Pharmaceuticals Inc. and certain executive employees (Filed With SEC on February 16, 2023)

Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)

Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)

Diffusion Pharmaceuticals Inc. (47) | Separation Agreements (5)